Skip to main content

Public Policy

By Jessica Hagen | 12:57 pm | July 03, 2023
The FDA-cleared and CE-marked image analysis software helps providers diagnose and monitor patients with neurological conditions.
By HIMSS TV | 07:00 am | July 03, 2023
Chad Peterson, managing director at NetSPI, discusses how care organizations can protect health information by ensuring HIPAA compliance – and what companies can do to reduce vulnerability through reconfiguration.
HIMSS23
By HIMSS TV | 07:00 am | June 27, 2023
The approach Connecticut is taking on AI is not to pause it because it has great potential but to keep a close eye on it, states Sumit Sajnani, health information technology officer at the Connecticut Office of Health Strategy.
By Jessica Hagen | 02:57 pm | June 20, 2023
BabySat, available via prescription, alerts parents when their baby's heart rate or blood oxygen saturation falls out of a prescribed range.
By HIMSS TV | 01:00 pm | June 20, 2023
Elena Sini, board of directors chair at HIMSS, alongside Hal Wolf, president and CEO of HIMSS, announce HIMSS European conference will be held in Rome, Italy in May of next year and provide teasers regarding the venue in the Eternal City.
HIMSS23
By HIMSS TV | 01:00 pm | June 15, 2023
Hal Wolf, HIMSS president and CEO, discusses the organization's announcement of establishing its international headquarters in Rotterdam and how it impacts HIMSS' chapters and partnerships working to advance digital transformation globally.
By Jessica Hagen | 01:26 pm | June 14, 2023
The company will first use the patent to combine the Apple Watch with Apple's new augmented reality headset Apple Vision Pro for closed loop AI-enabled treatment.
By Jessica Hagen | 01:53 pm | June 13, 2023
The FDA clearance comes just three months after the company received EU MDR Class IIb certification for its configurable disease management platform.
By Jessica Hagen | 01:38 pm | June 09, 2023
Alberta Spreafico, managing director of digital health and innovation at Healthware, shares how the report can guide companies' go-to-market strategies for entering the European market.
By Jessica Hagen | 01:00 pm | June 08, 2023
The company was also the first to receive emergency use authorization for its home COVID-19 test in 2021.